Unknown

Dataset Information

Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide.


ABSTRACT: Despite the understanding that renal clearance is pivotal for driving the pharmacokinetics of numerous therapeutic proteins and peptides, the specific processes that occur following glomerular filtration remain poorly defined. For instance, sites of catabolism within the proximal tubule can occur at the brush border, within lysosomes following endocytosis, or even within the tubule lumen itself. The objective of the current study was to address these limitations and develop methodology to study the kidney disposition of a model therapeutic protein. Exenatide is a peptide used to treat type 2 diabetes mellitus. Glomerular filtration and ensuing renal catabolism have been shown to be its principal clearance pathway. Here, we designed and validated a Förster resonance energy transfer-quenched

SUBMITTER: Bryniarski MA 

PROVIDER: S-EPMC9907348 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature